About Hangzhou Holypharm
Located in the cosmetic lab district of Hangzhou’s Yuhang District, Brightgene operates a state-of-the-art fermentation production facility spanning 5000m². The company’s capabilities include:
- Advanced R&D platforms for drug development
- Large-scale active ingredient manufacturing
- Copper peptide production exceeding 2 tons annually
- FDA, EU GMP, and PMDA certified facilities
From its base in Zhejiang province, Brightgene serves global pharmaceutical and cosmetic markets with its team of 83 specialized R&D professionals.
Frequently asked questions
Brightgene operates in the following areas:
- Active Pharmaceutical Ingredients (APIs)
- Fermentation semi-synthesis
- Multichiral drugs
- Non-biological macromolecules
- Inhalation preparations
- Conjugated drugs
- Production Services
- Large-scale fermentation
- Active ingredients manufacturing
- Copper peptide production
- Research Services
- Drug development
- Synthetic biology
- Biotechnology solutions
Brightgene holds these regulatory approvals and capabilities:
| Region | Certification |
|---|---|
| United States | FDA Approval |
| European Union | GMP Certification (3 products) |
| China | GMP Approval |
| Japan | PMDA Certification |
Technical foundations include:
- R&D Platforms
- Autonomous chassis cell database
- Screening models
- Analytical systems
- Quality Controls
- GMP standards
- Regulatory compliance
- Quality management systems
Brightgene maintains the following facilities and capabilities:
- Research Facilities
- 5000m² laboratory area
- 83 R&D personnel
- Advanced analytical equipment
- Production Infrastructure
- Industrial-scale fermentation lines
- Annual capacity: hundreds of tons of active ingredients
- 2+ tons copper peptide production capacity (2024)
- Technical Equipment
- NMR systems
- ICP-MS analyzers
- Screening model tools
More details about Hangzhou Holypharm
Leading biotechnology expertise in Hangzhou
Brightgene, established in 2001, operates as a cosmetic lab and pharmaceutical research facility in the Yuhang District of Hangzhou, China. With over two decades of experience in active ingredient development, the company has built a solid reputation in the biotech sector.
Advanced research and development capabilities
The facility spans over 5,000 square meters and houses 83 skilled R&D professionals, with 86% holding advanced degrees. The company has invested 180 million yuan in research and development, reflecting its commitment to innovation in the biotechnology field.
Technical expertise and production capacity
Brightgene’s technical platforms include:
- Fermentation semi-synthesis processes
- Advanced analytical equipment
- Autonomous chassis cell database
- Screening models editing tools
Manufacturing excellence and quality assurance
The company operates a large-scale fermentation production facility capable of producing hundreds of tons of active ingredients annually. By 2024, the copper peptide production capacity is set to exceed 2 tons, serving both cosmetic and pharmaceutical applications.
International certifications
Brightgene maintains high quality standards through:
- US FDA approval
- China GMP certification
- EU GMP certification for three product lines
- Japan PMDA certification
Strategic location in Zhejiang’s biotech hub
Located in the European and American Financial City of Hangzhou’s Yuhang District, Brightgene benefits from Zhejiang province’s growing biotechnology sector. This positioning allows for efficient distribution across Asian markets while maintaining global compliance standards.
Company gallery
